Determination of ketorolac in human serum by high-performance liquid chromatography

被引:2
作者
Chun, IK
Kang, HH
Gwak, HS
机构
[1] College of Pharmacy, Dongduck Women's University
[2] College of Pharmacy, Dongduck Women's University, Sungbuk-ku, Seoul 136-714
关键词
HPLC assay; ketorolac tromethamine; human serum;
D O I
10.1007/BF02986023
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A high-performance liquid chromatographic (HPLC) assay has been developed for the determination of ketorolac in human serum using a new extraction method with a good recovery. Human serum samples (1.0 mi) spiked with known concentrations of ketorolac tromethamine and 10 mu g of ketoprofen as the internal standard (IS) were acidified with 200 mu l of 1N HCl and extracted with 7 mi of n-hexane-ether (7:3 v/v). Extracts were centrifuged and organic layer was back-extracted with 400 mu l of 0.1% tromethamine solution. Twenty mu l of centrifuged aqueous layer was injected onto a reversed-phase octyl column and eluted with a mixture of acetonitrile, water, methanol, and triethylamine [35.55:10:0.1 (v/v), pH 3.0] at a flow rate of 1.0 ml/min. Ultraviolet detection of ketorolac and IS was carried out at 300 nm. The calibration curve obtained using peak area ratios showed a good linearity (in concentration range 10-150 ng/ml r(2)=0.9944; in range 50-2000 ng/ml, r(2)=0.9998). The mean intra-day accuracy and precision for this HPLC method were found to be 3.6 and 3.7%, respec tively. The mean inter-day accuracy and precision were found to be 4.0 and 3.7%, respec tively, in the concentration range 50-2000 ng/ml. The recovery of ketorolac from serum was 92.0 (+/-5.7)% at the concentration of 100 ng/ml. This method proved to be readily applicable to the assay of ketorolac in human serum.
引用
收藏
页码:529 / 534
页数:6
相关论文
共 19 条
[1]   KETOROLAC - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
BUCKLEY, MMT ;
BROGDEN, RN .
DRUGS, 1990, 39 (01) :86-109
[2]   REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF KETOROLAC AND ITS APPLICATION TO BIOEQUIVALENCE STUDIES IN HUMAN SERUM [J].
CHAUDHARY, RS ;
GANGWAL, SS ;
JINDAL, KC ;
KHANNA, S .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 614 (01) :180-184
[3]   COMPARATIVE BIOAVAILABILITY OF 2 ORAL FORMULATIONS OF KETOROLAC TROMETHAMINE - DOLAC(R) AND EXODOL(R) [J].
FLORESMURRIETA, FJ ;
GRANADOSSOTO, V ;
CASTANEDAHERNANDEZ, G ;
HERRERA, JE ;
HONG, E .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (02) :129-136
[4]  
FORBES JA, 1990, PHARMACOTHERAPY, V10, pS77
[5]   EVIDENCE AGAINST THE PARTICIPATION OF MU-OPIOID AND KAPPA-OPIOID RECEPTORS IN THE ANALGESIC ACTIVITY OF KETOROLAC IN RATS [J].
GRANADOSSOTO, V ;
FLORESMURRIETA, FJ ;
CASTANEDAHERNANDEZ, G ;
HONG, E ;
LOPEZMUNOZ, FJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (06) :514-517
[6]  
GU CL, 1987, PHARMACEUT RES, V4, P255
[7]  
GU L, 1988, INT J PHARM, V41, P95
[8]   PHARMACOKINETICS OF SINGLE-DOSE ORAL AND INTRAMUSCULAR KETOROLAC TROMETHAMINE IN THE YOUNG AND ELDERLY [J].
JALLAD, NS ;
GARG, DC ;
MARTINEZ, JJ ;
MROSZCZAK, EJ ;
WEIDLER, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (01) :76-81
[9]  
JAMALI F, 1989, J LIQ CHROMATOGR, V12, P1835
[10]   PHARMACOKINETICS OF KETOROLAC AND P-HYDROXYKETOROLAC FOLLOWING ORAL AND INTRAMUSCULAR ADMINISTRATION OF KETOROLAC TROMETHAMINE [J].
JUNG, D ;
MROSZCZAK, EJ ;
WU, A ;
LING, TL ;
SEVELIUS, H ;
BYNUM, L .
PHARMACEUTICAL RESEARCH, 1989, 6 (01) :62-65